Harvard Bioscience Stock Story

HBIO Stock  USD 4.24  0.04  0.95%   
About 53% of Harvard Bioscience's investor base is interested to short. The analysis of overall sentiment of trading Harvard Bioscience stock suggests that many investors are impartial at this time. Harvard Bioscience's investor sentiment overview provides quick insight into current market opportunities from investing in Harvard Bioscience. The current market sentiment, together with Harvard Bioscience's historical and current headlines, can help investors time the market. In addition, many technical investors use Harvard Bioscience stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Harvard Bioscience stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Harvard daily returns and investor perception about the current price of Harvard Bioscience as well as its diversification or hedging effects on your existing portfolios.
  

Requested story not found. it has been either deleted or moved. View all stories for Harvard Bioscience.

Harvard Bioscience Latest Timeline

Harvard Bioscience is listed for 4.24. About 78.0% of the company shares are owned by institutional investors. The book value of Harvard Bioscience was currently reported as 1.68. The company has Price/Earnings To Growth (PEG) ratio of 2.89. Harvard Bioscience recorded a loss per share of 0.08. The entity had not issued any dividends in recent years. The firm had 1319:1000 split on the 4th of November 2013.
When determining whether Harvard Bioscience offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Harvard Bioscience's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Harvard Bioscience Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Harvard Bioscience Stock:
Check out Harvard Bioscience Hype Analysis, Harvard Bioscience Correlation and Harvard Bioscience Performance.
To learn how to invest in Harvard Stock, please use our How to Invest in Harvard Bioscience guide.
You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Complementary Tools for Harvard Stock analysis

When running Harvard Bioscience's price analysis, check to measure Harvard Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Harvard Bioscience is operating at the current time. Most of Harvard Bioscience's value examination focuses on studying past and present price action to predict the probability of Harvard Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Harvard Bioscience's price. Additionally, you may evaluate how the addition of Harvard Bioscience to your portfolios can decrease your overall portfolio volatility.
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Is Harvard Bioscience's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Harvard Bioscience. If investors know Harvard will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Harvard Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.80)
Earnings Share
(0.08)
Revenue Per Share
2.646
Quarterly Revenue Growth
(0.01)
Return On Assets
0.011
The market value of Harvard Bioscience is measured differently than its book value, which is the value of Harvard that is recorded on the company's balance sheet. Investors also form their own opinion of Harvard Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Harvard Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Harvard Bioscience's market value can be influenced by many factors that don't directly affect Harvard Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Harvard Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Harvard Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Harvard Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.